Crossmark

Fluorescence molecular imaging of high-grade gliomas and brain metastases using the RAS70 peptide targeting plasma membrane-bound Hsp70 on tumor cells

Crossref DOI link: https://doi.org/10.1007/s11060-025-05245-0

Published Online: 2025-10-15

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nechaeva, Anastasiia

Ulitin, Alexei

Sitovskaya, Daria

Yudintceva, Natalia

Bobkov, Danila

Likhomanova, Ruslana

Olyushin, Victor

Kim, Aleksander

Samochernykh, Konstantin

Combs, Stephanie E.

Shevtsov, Maxim
Funding

Funding for this research was provided by:

Technische Universität München
License Information

Text and Data Mining valid from 2025-10-15

Version of Record valid from 2025-10-15
More Information

Article History

Received: 26 July 2025

Accepted: 6 October 2025

First Online: 15 October 2025

Declarations

:

: The research was approved by the Ethics Committee of the Almazov Medical Research Center (resolution No. 11–24 dated November 25, 2024) and was conducted in accordance with the Declaration of Helsinki. All patients received informed written consent to participate in the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below